Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease
The DOI matches its Crossref record; 85 of the 87 references it cites were found in a registry or an index.
Abstract
The amyloid beta-protein (Abeta) ending at 42 plays a pivotal role in Alzheimer's disease (AD). We have reported previously that intracellular Abeta42 is associated with neuronal apoptosis in vitro and in vivo. Here, we show that intracellular Abeta42 directly activated the p53 promoter, resulting in p53-dependent apoptosis, and that intracellular Abeta40 had a similar but lesser effect. Moreover, oxidative DNA damage induced nuclear localization of Abeta42 with p53 mRNA elevation in guinea-pig primary neurons. Also, p53 expression was elevated in brain of sporadic AD and transgenic mice carrying mutant familial AD genes. Remarkably, accumulation of both Abeta42 and p53 was found in some degenerating-shape neurons in both transgenic mice and human AD cases. Thus, the intracellular Abeta42/p53 pathway may be directly relevant to neuronal loss in AD. Although neurotoxicity of extracellular Abeta is well known and synaptic/mitochondrial dysfunction by intracellular Abeta42 has recently been suggested, intracellular Abeta42 may cause p53-dependent neuronal apoptosis through activation of the p53 promoter; thus demonstrating an alternative pathogenesis in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased p38MAPK activity has been reported in AD brains and lymphocytes [205,206,207,208], as well as in the cortex of a mouse model of AD [209].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [207]
In the citing paper
“Aβ42 peptides enhanced the transcription of p53, which is responsible for controlling cell apoptosis.412,413”
From Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future (2023) · cites this paper as [412]
Citations
Cites
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
Borchelt, D. R., Thinakaran, G., Eckman, C. B., Lee, M. K., Davenport, F., Ratovitsky, T., Prada, C.-M., Kim, G., Seekins, S., Yager, D., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80230-5 · Cited by 1,478
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., et al. (2004) · Science · doi:10.1126/science.1091230 · Cited by 1,303
The codon 72 polymorphic variants of p53 have markedly different apoptotic potential
Dumont, P., Leu, J. I.-J., Della Pietra, A. C., George, D. L., & Murphy, M. (2003) · Nature Genetics · doi:10.1038/ng1093 · Cited by 1,273
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Heat Shock Transcription Factors: Structure and Regulation
Wu, C. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.002301 · Cited by 1,231 · cited 7×
“Because HSF binds HSE in a trimeric form and the carboxyl termini are important for binding DNA (42), the differences in”
BackgroundInfluentialKawarabayashi, T., Younkin, L. H., Saido, T. C., Shoji, M., Ashe, K. H., & Younkin, S. G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00372.2001 · Cited by 1,053 · cited 2×
“aging from 4 months old (28), whereas extracellular Aβ is deposited from 8 to 12 months old (48) in Swedish 670/671 mutant APP-Tg mice (Tg2576) brain.”
BackgroundSelf-citationIntraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991 · cited 2×
“Intraneuronal Aβ42 has been shown to have cytosolic granular immunoreactivities in AD or DS sections (14, 15, 17), and recent immunoelectron microscopic studies have shown that Aβ42 accumulates in multivesicular bodies (29, 54).”
BackgroundSelf-citationOxidative stress in Alzheimer’s disease
Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00040-5 · Cited by 895
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease
Hock, C., Konietzko, U., Streffer, J. R., Tracy, J., Signorell, A., Müller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00294-0 · Cited by 777
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
Westerman, M. A., Cooper-Blacketer, D., Mariash, A., Kotilinek, L., Kawarabayashi, T., Younkin, L. H., Carlson, G. A., Younkin, S. G., & Ashe, K. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01858.2002 · Cited by 718
Self-citationTakahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706
Norbury, C. J., & Zhivotovsky, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207532 · Cited by 701
Mielke, K., & Herdegen, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00042-8 · Cited by 490
Evidence for Apoptotic Cell Death in Alzheimer's Disease
Smale, G., Nichols, N. R., Brady, D. R., Finch, C. E., & Horton, W. E. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1025 · Cited by 488
Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:65 · Cited by 475
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
Lassmann, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., & Wisniewski, H. M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294257 · Cited by 458
Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain
Takahashi, R. H., Almeida, C. G., Kearney, P. F., Yu, F., Lin, M. T., Milner, T. A., & Gouras, G. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5167-03.2004 · Cited by 445 · cited 1×
“Intraneuronal Aβ42 has been shown to have cytosolic granular immunoreactivities in AD or DS sections (14, 15, 17), and recent immunoelectron microscopic studies have shown that Aβ42 accumulates in multivesicular bodies (29, 54).”
BackgroundZhang, Y., McLaughlin, R., Goodyer, C., & LeBlanc, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110119 · Cited by 418 · cited 4×
“To collect intranuclear Aβ42 from Aβ42-transfected cells, 100 μg of NEP (34) was dialyzed to remove the salts and then was incubated with ~40 μg beads in a total volume of 100 μl.”
BackgroundMethodInfluentialAlzheimer's disease and Aβ toxicity: from top to bottom
Small, D. H., Mok, S. S., & Bornstein, J. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086072 · Cited by 394
D'Andrea, M. R., Nagele, R. G., Wang, H., Peterson, P. A., & Lee, D. H. S. (2001) · Histopathology · doi:10.1046/j.1365-2559.2001.01082.x · Cited by 390 · cited 3×
“Intraneuronal Aβ42 has been shown to have cytosolic granular immunoreactivities in AD or DS sections (14, 15, 17), and recent immunoelectron microscopic studies have shown that Aβ42 accumulates in multivesicular bodies (29, 54).”
BackgroundBusciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., & Yankner, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00604-9 · Cited by 387
Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters
Weinmann, A. S., Bartley, S. M., Zhang, T., Zhang, M. Q., & Farnham, P. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6820-6832.2001 · Cited by 384
Greenfield, J. P., Tsai, J., Gouras, G. K., Hai, B., Thinakaran, G., Checler, F., Sisodia, S. S., Greengard, P., & Xu, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.742 · Cited by 366 · cited 1×
“Although Aβ42 produced in endoplasmic reticulum (ER) is physiologically secreted to extracellular space (1, 9, 13), recent pathological studies suggest that Aβ42 accumulates in neurons before plaque formation in AD (14, 15) and Down syndrome (DS; 16, 17).”
BackgroundSelf-citationChui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., et al. (1999) · Nature Medicine · doi:10.1038/8438 · Cited by 364 · cited 13×
“Moreover, we have recently found enhanced generation of intracellular Aβ42 by FAD mutations in PS1 and PS2 in cultured cells (85).”
BackgroundSelf-citationWirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., Pradier, L., Beyreuther, K., & Bayer, T. A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01876-6 · Cited by 336
Evidence that Aβ42 is the real culprit in alzheimer's disease
Younkin, S. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370303 · Cited by 333
Shin, R., Iwaki, T., Kitamoto, T., & Tateishi, J. (1991) · PubMed · Cited by 318
Self-citationMitochondrial dysfunction, apoptotic cell death, and Alzheimer’s disease
Eckert, A., Keil, U., Marques, C. A., Bonert, A., Frey, C., Schüssel, K., & Müller, W. E. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00534-3 · Cited by 309
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
de la Monte, S. M., Sohn, Y. K., & Wands, J. R. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00131-7 · Cited by 307
Human HSP70 promoter contains at least two distinct regulatory domains.
Wu, B. J., Kingston, R. E., & Morimoto, R. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.3.629 · Cited by 305
Kaeser, M. D., & Iggo, R. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012283399 · Cited by 302
p38 Kinase Mediates UV-induced Phosphorylation of p53 Protein at Serine 389
Huang, C., Ma, W.-Y., Maxiner, A., Sun, Y., & Dong, Z. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12229 · Cited by 275
Intraneuronal Aβ42 accumulation in Down syndrome brain: Original Articles
Mori, C., Spooner, E. T., Wisniewski, K. E., Wisniewski, T. M., Yamaguchi, H., Saido, T. C., Tolan, D. R., Selkoe, D. J., & Lemere, C. A. (2002) · Amyloid · doi:10.3109/13506120208995241 · Cited by 255 · cited 1×
“Intraneuronal Aβ42 has been shown to have cytosolic granular immunoreactivities in AD or DS sections (14, 15, 17), and recent immunoelectron microscopic studies have shown that Aβ42 accumulates in multivesicular bodies (29, 54).”
BackgroundIntraneuronal Aβ-Amyloid Precedes Development of Amyloid Plaques in Down Syndrome
Gyure, K. A., Durham, R., Stewart, W. F., Smialek, J. E., & Troncoso, J. C. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0489-iaapdo · Cited by 248
Magrané, J., Smith, R. C., Walsh, K., & Querfurth, H. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4330-03.2004 · Cited by 242
Defective ubiquitination of cerebral proteins in Alzheimer's disease
L�pez Salon, M., Morelli, L., Casta�o, E. M., Soto, E. F., & Pasquini, J. M. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20001015)62:2<302::aid-jnr15>3.0.co;2-l · Cited by 224
Intracellular Mechanisms of Amyloid Accumulation and Pathogenesis in Alzheimer's Disease
Glabe, C. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:137 · Cited by 222 · cited 1×
“Although intraneuronal Aβ42 is reported to be associated with dysfunction of mitochondrias (26), lysosomes (27, 28), and synapses (29), intranuclear Aβ42 might have a novel pathogenesis related to apoptosis.”
BackgroundP38 MAP kinase is activated at early stages in Alzheimer's disease brain
Sun, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00180-8 · Cited by 219
Immunotherapeutic Approaches to Alzheimer's Disease
Monsonego, A., & Weiner, H. L. (2003) · Science · doi:10.1126/science.1088469 · Cited by 217
Giovanni, A., Keramaris, E., Morris, E. J., Hou, S. T., O'Hare, M., Dyson, N., Robertson, G. S., Slack, R. S., & Park, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11553 · Cited by 205
p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
Duan, W., Zhu, X., Ladenheim, B., Yu, Q., Guo, Z., Oyler, J., Cutler, R. G., Cadet, J. L., Greig, N. H., & Mattson, M. P. (2002) · Annals of Neurology · doi:10.1002/ana.10350 · Cited by 204
Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?
Dickson, D. W. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422317 · Cited by 201
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187 · cited 1×
“Although the incidence of neuronal apoptosis is increased in AD (22, 23), intracellular Aβ42, but not extracellular Aβ, induces neuronal apoptosis in vitro (24).”
BackgroundTheoretical models of the ion channel structure of amyloid beta-protein
Durell, S. R., Guy, H. R., Arispe, N., Rojas, E., & Pollard, H. B. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80717-9 · Cited by 175
Biogenesis and metabolism of Alzheimer’s disease Aβ amyloid peptides
Evin, G., & Weidemann, A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00063-3 · Cited by 170
p53 regulation of DNA excision repair pathways
Smith, M. L. (2002) · Mutagenesis · doi:10.1093/mutage/17.2.149 · Cited by 162
Relationship between β-amyloid degradation and the 26S proteasome in neural cells
Lopez Salon, M., Pasquini, L., Besio Moreno, M., Pasquini, J. M., & Soto, E. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00060-2 · Cited by 158
Roperch, J.-P., Alvaro, V., Prieur, S., Tuynder, M., Nemani, M., Lethrosne, F., Piouffre, L., Gendron, M.-C., Israeli, D., Dausset, J., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-835 · Cited by 152
Structural organization of the human heme oxygenase gene and the function of its promoter
SHIBAHARA, S., SATO, M., MULLER, R. M., & YOSHIDA, T. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb14583.x · Cited by 140
Alves da Costa, C., Paitel, E., Mattson, M. P., Amson, R., Telerman, A., Ancolio, K., & Checler, F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062059899 · Cited by 133
Self-citationMutant ubiquitin expressed in Alzheimer's disease causes neuronal death 1
De Vrij, F. M. S., Sluijs, J. A., Gregori, L., Fischer, D. F., Hermens, W. T. J. M. C., Goldgaber, D., Verhaagen, J., Van Leeuwen, F. W., & Hol, E. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0438com · Cited by 123
Sun, X., Shimizu, H., & Yamamoto, K.-I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4489 · Cited by 122
Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice.
LaFerla, F. M., Hall, C. K., Ngo, L., & Jay, G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118957 · Cited by 114
Nuclear factor – κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug
Hellin, A., Calmant, P., GIELEN, J. E., Bours, V., & Merville, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201638 · Cited by 96
Zhang, Y., Hong, Y., Bounhar, Y., Blacker, M., Roucou, X., Tounekti, O., Vereker, E., Bowers, W. J., Federoff, H. J., Goodyer, C. G., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-19-07385.2003 · Cited by 92
White, A. R., Zheng, H., Galatis, D., Maher, F., Hesse, L., Multhaup, G., Beyreuther, K., Masters, C. L., & Cappai, R. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06207.1998 · Cited by 88
Xu, X., Yang, D., Wyss-Coray, T., Yan, J., Gan, L., Sun, Y., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7547 · Cited by 87
Gilman, C. P., Chan, S. L., Guo, Z., Zhu, X., Greig, N. H., & Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:3:159 · Cited by 85
Seidl, R., Fang-Kircher, S. G., Bidmon, B., Cairns, N. J., & Lübec, G. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00945-8 · Cited by 78
Apoptotic neurons in Alzheimer's disease frequently show intracellular Aβ42 labeling
Chui, D. H., Dobo, E., Makifuchi, T., Akiyama, H., Kawakatsu, S., Petit, A., Checler, F., Araki, W., Takahashi, K., & Tabira, T. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3208 · Cited by 74
Self-citationEmerging Alzheimer’s disease therapies: inhibition of β-secretase
Citron, M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00122-7 · Cited by 74
Perspectives on the Amyloid-β Cascade Hypothesis
Lee, H., Casadesús, G., Zhu, X., Joseph, J. A., Perry, G. L., & Smith, M. A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6205 · Cited by 73
Changes in gene expression induced by H2O2 in cardiac myocytes
Kemp, T. J., Causton, H. C., & Clerk, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01215-4 · Cited by 73
Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice
Shie, F.-S., LeBoeur, R. C., & Jin, L.-W. (2003) · NeuroReport · doi:10.1097/00001756-200301200-00023 · Cited by 70
Selective increase in cellular Aβ42 is related to apoptosis but not necrosis
Ohyagi, Y., Yamada, T., Nishioka, K., Clarke, N. J., Tomlinson, A. J., Naylor, S., Nakabeppu, Y., Kira, J.-I., & Younkin, S. G. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00033 · Cited by 69
Self-citationB�ckig, A., Tikkanen, R., Herzog, V., & Schmitz, A. (2002) · Histochemistry and Cell Biology · doi:10.1007/s00418-002-0459-2 · Cited by 67
DNA damage checkpoints: Implications for cancer therapy
O'Connor, P. M., & Fan, S. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5873-6_16 · Cited by 64
p53 and Apoptosis: It's Not Just in the Nucleus Anymore
Manfredi, J. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00106-0 · Cited by 63
Zandi, E., Tran, T. N., Chamberlain, W., & Parker, C. S. (1997) · Genes & Development · doi:10.1101/gad.11.10.1299 · Cited by 57
Wang, R., Zhou, J., & Tang, X. C. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00402-3 · Cited by 57
Enhanced generation of intracellular Aβ42 amyloid peptide by mutation of presenilins PS1 and PS2
Takeda, K., Araki, W., & Tabira, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2003.03135.x · Cited by 53
Self-citationMaf Transcriptionally Activates the Mouse p53Promoter and Causes a p53-dependent Cell Death
Hale, T. K., Myers, C., Maitra, R., Kolzau, T., Nishizawa, M., & Braithwaite, A. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000921200 · Cited by 49
Detection and quantitation of cellularly derived amyloid β peptides by immunoprecipitation‐HPLC‐MS
Clarke, N. J., Tomlinson, A. J., Ohyagi, Y., Younkin, S. G., & Naylor, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00706-6 · Cited by 43
Self-citationWilson, C., Henry, S. E., Smith, M. A., & Bowser, R. P. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00496.x · Cited by 41
Antigen Retrieval by Heating En Bloc for Pre-fixed Frozen Material
Ino, H. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100803 · Cited by 41
The amyloid β peptide Aβ (25–35) induces apoptosis independent of p53
Blasko, I., Wagner, M., Whitaker, N., Grubeck-Loebenstein, B., & Jansen-Dürr, P. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01323-5 · Cited by 35
Yeung, M. C., GEERTSMA, F. R., Liu, J., & Lau, A. S. Y. (1998) · AIDS · doi:10.1097/00002030-199804000-00002 · Cited by 29
Resnick, J. M., Cherwitz, D. L., Knapp, D., Uhlman, D. L., & Niehans, G. A. (1995) · PubMed · Cited by 28
Nuclear and Cytoplasmic Localization of the β-Amyloid Peptide (1–43) in Transfected 293 Cells
Johnstone, E. M., Babbey, L. E., Stephenson, D. T., Paul, D. C., Santerre, R. F., Clemens, J. A., Williams, D. C., & Little, S. P. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0469 · Cited by 26
Research works printed but not linked: 1
- 10.1172/jci22317 · doi:10.1172/jci22317 · Paper page
Cited by
Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., Finch, C. E., St. Laurent III, G., Kenny, P. J., & Wahlestedt, C. (2008) · Nature Medicine · doi:10.1038/nm1784 · Cited by 1,416
Amyloid β-based therapy for Alzheimer’s disease: Challenges, successes and future
Zhang, Y., Chen, H., Li, R., Sterling, K., & Song, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01484-7 · Cited by 988
Molecular mechanisms of cell death in neurological diseases
Moujalled, D., Strasser, A., & Liddell, J. R. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00814-y · Cited by 749
Bonfili, L., Cecarini, V., Berardi, S., Scarpona, S., Suchodolski, J. S., Nasuti, C., Fiorini, D., Boarelli, M. C., Rossi, G., & Eleuteri, A. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-02587-2 · Cited by 453
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Metadata
- Authors
- Ohyagi, Y., Asahara, H., Chui, D.-H., Tsuruta, Y., Sakae, N., Miyoshi, K., Yamada, T., Kikuchi, H., Taniwaki, T., Murai, H., Ikezoe, K., Furuya, H., Kawarabayashi, T., Shoji, M., Checler, F., Iwaki, T., Makifuchi, T., Takeda, K., Kira, J.-I., & Tabira, T.
- Affiliations
- Kyushu University (JP)
- National Center of Neurology and Psychiatry (JP)
- Okayama University (JP)
- Institut de Pharmacologie Moleculaire et Cellulaire Valbonne France
- Saigata National Hospital (JP)
- National Institute for Longevity Sciences Aichi Japan
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-11-17
- Volume
- 19
- Issue
- 2
- Pages
- 1-29
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2131081669
- Cited by
- 281
- References
- 87
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 9 · 2023: 14 · 2022: 8 · 2021: 12 · 2020: 12 · 2019: 9 · 2018: 8 · 2017: 10 · 2016: 14 · 2015: 9 · 2014: 12 · 2013: 14 · 2012: 16
- FWCI
- 8.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Takeda Pharmaceutical Company (BC-05, BA-27)
- Kumamoto University (Saos-2, U-20S)
- Japan Health Sciences Foundation
- Kyushu University
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Aβ40, p53-dependent apoptosis, Alzheimer's disease, neurodegeneration, neuronal apoptosis, oxidative DNA damage, sporadic Alzheimer's disease, neuronal loss
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Animals, Brain, Brain Chemistry, Cells, Cultured, Cytosol, DNA, Female, Fetus, Guinea Pigs, Humans, Hydrogen Peroxide, Leucine, Male, Membrane Proteins, Mice, Mutant Strains, Mice, Transgenic, Nerve Degeneration, Neuroblastoma, Neurons, Peptide Fragments, Promoter Regions, Genetic, Protein Binding, RNA, Messenger, Tumor Cells, Cultured, Valine, Genes, p53, Tumor Suppressor Protein p53, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Apoptosis, Heat-Shock Response, Mutation, Missense, Response Elements, Intracellular Space, Mice, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.